QC
EXAS

Quantessence Capital’s Exact Sciences EXAS Stock Holding History

Quantessence Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,074
Closed -$1.39M – 225
2025
Q2 		$1.39M Buy
+26,074
New +$1.32M 0.41% 53

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantessence Capital's EXAS Position: Q3 2025 in Review

Quantessence Capital sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 26,074 shares — an estimated $1.39M sold.

Quantessence Capital first reported a position in EXAS in Q2 2025 and held it in 1 quarter. The position peaked at $1.39M in Q2 2025. 567 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

  • Quantessence Capital reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
  • Quantessence Capital sold 26,074 Exact Sciences shares in Q3 2025, an estimated $1.39M.
  • Quantessence Capital first reported a position in Exact Sciences in Q2 2025 and held it in 1 quarter.
  • Quantessence Capital's Exact Sciences position peaked at $1.39M in Q2 2025.
  • 567 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on Quantessence Capital's 13F filing for Q3 2025, filed 14 Nov 2025.